TABLE 1.
Organoid-based toxicity assessment.
Organoid type | Organoid sources | Fabrication methods | Characteristics | Test substances | Toxic endpoints | References |
---|---|---|---|---|---|---|
Liver organoid | ESCs | Differentiation of ESCs into foregut endoderm progenitor populations that are further maturated into hepatic progenitor cells by the WNT signaling pathway, then cultured under 3D suspension culture conditions | By selecting the size of the organoids, it is possible to produce a more complex structure, including cholangiocytes and stromal cells, in case of large organoids | Acetaminophen | Viability (WST-1) | Sgodda et al. (2017) |
Primary human hepatocytes, hepatic stellate cells, and Kupffer cells | Produced with a mixture of 80% hepatocytes, 10% hepatic stellate cells, and 10% Kupffer cells and seeded onto non-adherent, round-bottomed plates | Composed of a representative population of cells in vivo, capable of maintaining high viability over a long period of time, and is metabolically active, able to respond to and metabolize drugs accurately | Environmental toxins (glyphosate, lead, mercury, thallium) | Viability (ATP and live cell staining) | Forsythe et al. (2018) | |
Human liver tissue | Isolation of duct cells from human liver tissue by chopping and enzyme digestion, and embedding of the isolated duct cells in Matrigel followed by the addition of differentiation factors | Shows the characteristics of hepatocytes rather than HepG2 cells such as positive nuclear staining of HNF4A, clear positive glycogen accumulation, and a more stable albumin secretion | PL-inducing drugs (amikacin, amiodarone, sertraline, acetaminophen) | Viability (ATP), morphological changes, albumin secretion, expression of genes related to phospholipidosis | Lee et al. (2020) | |
iPSCs | Differentiation of iPSCs into foregut, dissociation into single cells, and culture in a specialized medium to enhance organoid formation, followed by harvesting and resuspension in Matrigel on the Ultra-Low Attachment Multiwell Plate | Exhibits properties that include bile transport functions, allows assessment of susceptibility based on polymorphism at organoid resolution, and is amenable to high-throughput toxicity screening | 238 marketed drugs including 206 DILI compounds and 32 non-DILI compounds | Biliary excretion capacity, cell viability (ATP), and mitochondrial membrane potential | Shinozawa et al. (2021) | |
Cardiac organoid | iPSCs and fibroblasts | Cell suspension consisted of 90% iPSC-derived CMs; 10% cardiac fibroblasts were suspended in a hydrogel, seeded in a specialized culture platform microwell (Biowire™ II), and subjected to a 10-weeks electrical field stimulation to promote maturation | Shows positive force frequency and post-rest potentiation and improved sarcomeric organization and is enriched for gene expression patterns of the corresponding adult human heart cardiac regions, enables polygenic cardiac disease modeling | 6 cardioactive drugs (Zhao et al.), 12 cardioactive drugs (Feric et al.) and 8 reported positive inotropes (Qu et al.) | Contractility, Calcium transients, and gene expression related to cardiotoxicity pathway | Zhao et al. (2019), Feric et al. (2019),Qu et al. (2020) |
ESCs and fibroblasts | Cell suspension consisted of 90% ESC-derived CMs, and 10% dermal fibroblasts were re-suspended in aqueous scaffold materials (Matrigel and collagen I solution) in a dedicated bioreactor, followed by gelation and self-assembly during incubation to fabricate a miniature cardiac organoid that mimics a human ventricle | Shows organized sarcomeres with myofibrillar microstructures, upregulation of key genes related to calcium-handling, ion channel, and cardiac-specific proteins and allows direct measurement of stroke volume, EF, cardiac output, pressure volume loop, and so on | 6 cardioactive drugs (Li et al.) and 25 cardioactive drugs (Keung et al.) | Contractility | Li et al., 2018, Keung et al., 2019 | |
Cardiac organoid | iPSCs, hCMECs, and hCFs | Cell suspensions of iPSC-derived CMs, hCMECs, and hCFs in a ratio of 4:2:1 were seeded in ultra-low attachment spheroid microplates | Exhibits typical morphological and cellular compositional characteristics similar to those present in myocardium and are amenable to high-throughput toxicity screening | 15 FDA approved structural cardiotoxins and 14 FDA approved nonstructural cardiotoxins | Viability (ATP), endoplasmic reticulum integrity, and mitochondrial membrane potential | Archer et al. (2018) |
iPSCs-CMs, hCFs, HUVECs, and hADSCs | A cell suspension composed of 50% iPSC-derived CMs and 50% non-myocytes (at a 4:2:1 ratio of FBs: HUVECs: hADSCs) was seeded into agarose hydrogel molds and submerged with culture medium, followed by incubation under hypoxic conditions and treatment with noradrenaline | Mimics the characteristics of myocardial infarction, including pathological metabolic changes, fibrosis and altered calcium handling, at transcriptomic, structural, and functional levels | doxorubicin | Contractility and apoptosis (TUNEL staining) | Richards et al. (2020) | |
Kidney organoid | ESCs and iPSCs | Differentiation of 3D cultured PSC-derived cavitated spheroids into segmented, nephron-like kidney organoids by GSK3b inhibition to result in cell population with proximal tubular, podocyte, and endothelial characteristics | 3D culture system that reconstitutes functional, structured epithelia modelling the epiblast, kidney tubular cells, and podocyte-like cells | cisplatin and gentamicin | Expression of kidney injury biomarker (Kim-1) | Freedman et al. (2015) |
ESCs and iPSCs | PSC-derived intermediate mesoderm was treated with GSK-3b inhibitor and FGF9 to differentiate into nephron progenitor cells of metanephric mesenchyme and to further induce pretubular aggregates and renal vesicles | Contains epithelial nephron-like structures expressing markers of podocytes, proximal tubules, loops of Henle, and distal tubules in an organized, continuous arrangement | gentamicin and cisplatin | Expression of kidney injury biomarker (Kim-1) | Morizane et al. (2015) | |
iPSCs | Monolayer culture of PSC-derived posterior primitive streak to induce intermediate mesoderm, followed by a 3D culture to promote self-organizing nephrogenic events leading to organoid formation | Contains nephrons associated with a collecting duct network surrounded by renal interstitium and endothelial cells | cisplatin | Apoptosis (caspase-3) | Takasato et al. (2015) | |
Renal fibroblasts, huvec, and RPTECs | Renal fibroblasts and huvec were combined in a 50:50 ratio and seeded into a microwell plate using a 3D bioprinter, followed by the addition of RPTECs | Shows formation of extensive microvascular networks and tight junctions and expression of renal uptake and efflux transporters | cisplatin | Viability (LDH release) and expression of genes related to fibrosis (TGF beta) | King et al., 2017 | |
Intestinal organoid | Ileal small intestinal tissue | Digested human primary ileal tissue, isolated intestinal crypts by passing the minced tissue sections through filter mesh, and suspended in Matrigel and cultured in a specialized medium | Enteroids collected with a mean diameter of 600 μm indicate the presence of Paneth cells, enteroendocrine cells, goblet cells, and enterocytes | 31 marketed diarrheagenic and non-diarrheagenic drugs | Viability (ATP) | Belair et al. (2020) |
fibroblasts and primary small intestinal epithelial cells | Generated by seeding small intestinal epithelial cells on a supportive layer of fibroblasts under air-liquid interface conditions in a transwell format | Composed of a monolayer of simple columnar epithelial cells with basally positioned nuclei, consistent with enterocytes | 39 marketed drugs with different diarrhea-genic risk | Barrier function and Cell proliferation (MTT assay) | Peters et al. (2019) | |
Brain organoid | iPSCs | Cultured embryoid bodies generated from iPSC were embedded in Matrigel and seeded onto plates in organoid differentiation media to form cerebral organoids and then transferred to a spinner platform for long-term culture | Exhibits similar developmental. Patterns and contains multiple types of brain cells (NSCs, neurons, and astrocytes), and distinct multi-layered, cortical-like neuronal zone and choroid plexus | Ethanol | Caspase 3 activity and functional and morphological alterations of mitochondria | Arzua et al. (2020) |
ESCs | ESC-derived cerebral organoids generated by adding dual SMAD-signaling inhibitors to neural induction medium to promote neuroepithelial expansion and recapitulate fetal cerebral development in vitro | Displays the features of brain development, including the expression of neural stem cells, neurons, and astrocyte markers, indicating cerebral organoid stages up to early fetal stage | acrylamide | Apoptosis, expression of genes related to the NRF2 pathway, and tau phosphorylation | Bu et al. (2020) | |
iPSCs | Embryoid bodies differentiated from iPSC were cultured in a selected growth factors and ECM culture conditions to generate neuroectoderm, followed by development into neural epithelial tissue, then plated and incubated on an orbital shaker to form cerebral organoids | Exhibits complex morphology and neuron-specific cell differentiation and expresses marker genes related to forebrain, hippocampus, hindbrain, and prefrontal cortex | vincristine | Caspase 3 activity | Liu et al. (2019) | |
iPSCs | Neural progenitor cells differentiated from iPSC were differentiated into brainspheres by incubating in a dedicated differentiation medium under constant gyratory shaking for up to 8 weeks | Expresses mature neuronal markers (NF200, βIII-tubulin and MAP2), astrocytic marker GFAP, and oligodendrocyte marker O1, indicating that diverse neuronal and glial cell populations are present | rotenone | Reactive oxygen species (ROS) and mitochondrial function | Pamies et al. (2018) |